Pfizer to pay Sanofi-Aventis $1.3 billion for insulin

&to=' target=_blank>Pfizer Inc., the world's biggest drug company, will pay $1.3 billion (Ђ1.1 billion) to Sanofi-Aventis Group to obtain full worldwide rights to the inhaled insulin the companies developed jointly and were planning to co-market. U.S. regulators are expected to rule upon the drug later this month.

Pfizer, known for blockbusters such as the cholesterol drug Lipitor, made the announcement late Thursday.

Subscribe to Pravda.Ru Telegram channel, Facebook, RSS!

Author`s name Editorial Team